The global pharmaceutical market is booming, growing to an estimated $1.6 trillion in 2023 and projected to hit nearly $2.3 trillion by 2028! At the heart of this incredible growth is the Indian pharmaceutical industry. Ranking third in the world…
Syrup vs. Suspension: What’s the Real Difference? In the world of liquid medications, the terms “syrup” and “suspension” are often used interchangeably in casual conversation. However, in pharmaceutical science, syrups and suspensions represent two fundamentally different approaches to delivering medicine.…
Karnal, strategically located in Haryana’s NCR, has quietly emerged as one of India’s most promising pharmaceutical manufacturing destinations. With a current industry turnover of Rs. 1,000 crore, 150+ active MSMEs, and 10,000 direct employees, the sector is experiencing exponential growth. The Haryana government’s…
Cefixime is an oral third-generation cephalosporin antibiotic that has been a cornerstone of bacterial infection management in India for decades. This medication works by inhibiting bacterial cell wall synthesis, effectively halting the growth and reproduction of susceptible pathogens. As a…
Prolonged release vs sustained release tablets sit under the broader “modified release” family but differ in their pharmacokinetic goals, release kinetics, and clinical use cases. Understanding these nuances is essential for formulation scientists, regulatory teams, and plant owners when designing…
In the pharmaceutical industry, a variance of just 0.1 pH can mean the difference between a stable, effective drug and a failed batch. From buffer preparation in Quality Control (QC) to monitoring bioreactors in production, the pH meter is perhaps…